Webinar Date/Time: Mon, Feb 13, 2023 10:00 AM EST
Technological innovations, market need, and evolving regulatory requirements have led to a rapid growth in Point of Care (POC) testing and devices. This webinar will help you understand the use of POC devices to support clinical research, learn key development and regulatory requirements for POC devices and use decentralized study models to support evidence generation for POC development.
Register Free: http://www.appliedclinicaltrialsonline.com/act/poc
Event Overview:
Technological innovations, market need, and evolving regulatory requirements has led to a rapid growth in Point of Care (POC) testing and devices. POC testing involves medical diagnostic tests performed outside a laboratory environment, and increasingly in the home setting. Home-use devices aid in the early detection of potential health conditions in the absence of symptoms, facilitate early and more optimal treatment interventions and reduce burden on healthcare systems. The evolution of home-use devices and changing regulatory landscape and evidence requirements presents challenges for clinical researchers that require innovative and robust operational and technical solutions.
Key Learning Objectives:
Who Should Attend:
Pharmaceutical, biotechnology, medical device, and diagnostics companies - areas within companies: data analysis, health economics, outcomes research, medical affairs, clinical research, clinical trials, innovation, technology, project management, real-world evidence
Speakers
Andy Bevan
MRes CBiol CSci MRSB, Executive Director, Peri- and Post-approval Studies
PPD
Ken Butz
MS, Director, Regulatory Affairs, Medical Devices and Diagnostics
PPD
Tom Healy
Senior Director, Data Architecture, Digital and Decentralized Solutions
PPD
Margaret Moos
MS, Business Optimization Lead, Executive Director, Project Delivery
PPD
Christine Varner
Director, Non-Interventional Studies
PPD
Register Free: http://www.appliedclinicaltrialsonline.com/act/poc
New FDA Initiative Reveals Common Reasons for Drug Application Rejection
July 11th 2025By publishing more than 200 complete response letters, the FDA is offering new visibility into the issues that most often delay drug approvals, including safety concerns, trial design flaws, and manufacturing gaps.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Effect of AI/ML, Real World Evidence and Master Protocols on Trial Success
July 7th 2025How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical oversight and increased collaboration, are contributing to better healthcare delivery and strengthening the role of clinical research in driving global health progress.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.